Brenda Kwambana-Adams Selected Research

Brenda Kwambana-Adams Research Topics

4	Pneumococcal Infections 01/2023 - 01/2019
3	Pneumococcal Meningitis (Streptococcus pneumoniae Meningitis) 01/2021 - 01/2019
3	Meningitis 01/2021 - 01/2019
2	Lung Diseases (Lung Disease) 01/2023 - 01/2022
2	Bacterial Meningitis 01/2021 - 01/2019
1	Infections 01/2021
1	Necrosis 01/2019
1	Diarrhea 10/2017

5	VaccinesIBA 01/2021 - 01/2019
4	Conjugate VaccinesIBA 01/2023 - 01/2019
3	Anti-Bacterial Agents (Antibiotics)IBA 01/2022 - 10/2017
2	Azithromycin (Zithromax)FDA LinkGeneric 01/2023 - 01/2022
2	Bacterial VaccinesIBA 01/2021 - 01/2019
2	Virulence Factors (Pathogenicity Factors)IBA 01/2019 - 10/2017
1	10-valent pneumococcal conjugate vaccineIBA 01/2023
1	LincosamidesIBA 01/2022
1	TetracyclinesIBA 01/2022
1	beta Lactam AntibioticsIBA 01/2021
1	Panton-Valentine leukocidinIBA 01/2019
1	Enterotoxins (Enterotoxin)IBA 10/2017
1	Ampicillin (Omnipen)FDA LinkGeneric 10/2017
1	Trimethoprim (Proloprim)FDA LinkGeneric 10/2017
1	Shiga Toxin (Shigella Toxin)IBA 10/2017
1	(N- (2- ((4- ((2- ((4- (9- acridinylamino)phenyl)amino)- 2- oxoethyl)amino)- 4- oxobutyl)amino)- 1- (1H- imidazol- 4- ylmethyl)- 1- oxoethyl)- 6- (((- 2- aminoethyl)amino)methyl)- 2- pyridinecarboxamidato) iron(1+)IBA 10/2017
1	Sulfamethoxazole FDA LinkGeneric 10/2017